SHL Telemedicine (LTS:0QMX) Moat Score: 5/10 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QMX SHL Telemedicine Ltd LTS:0QMX
45 GF Score
Price CHF1.05
GF Value CHF2.62
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is SHL Telemedicine Moat Score?

SHL Telemedicine LTS:0QMX -0.01% 45 Moat Score is 5 as of Jul. 14, 2026. GuruFocus rates LTS:0QMX with a GF Score™ of 45/100 and a GF Value™ of CHF2.62 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 676 Healthcare Providers & Services companies, SHL Telemedicine ranks better than 96.01% on this metric.

SHL Telemedicine has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

SHL Telemedicine has Narrow Moat: SHL Telemedicine has a solid narrow moat with a strong position in telemedicine, benefiting from valuable intellectual property and regulatory barriers. However, it lacks the brand strength and customer loyalty needed for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes SHL Telemedicine might have Narrow Moat - Solid narrow moat.

SHL Telemedicine  (LTS:0QMX) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

SHL Telemedicine Moat Score Related Terms

LTS:0QMX vs VEEV, BTSG, TEM: Moat Score Comparison

For the Health Information Services subindustry, SHL Telemedicine's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SHL Telemedicine Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Moat Score distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's Moat Score falls into.


LTS:0QMX
45GF Score
SHL Telemedicine Ltd LTS:0QMX
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
SHL Telemedicine (LTS:0QMX) has a Moat Score of 5 as of Jul. 14, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, SHL Telemedicine ranks #27 out of 676 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is SHL Telemedicine's Moat Score too high?
SHL Telemedicine's current Moat Score is 5. Based on the distribution chart, SHL Telemedicine ranks #27 out of 676 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, SHL Telemedicine has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Moat Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #27 out of 676 companies for Moat Score. This places SHL Telemedicine in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. SHL Telemedicine's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
Based on GuruFocus' analysis, SHL Telemedicine (LTS:0QMX) is currently considered Possible Value Trap. The stock's GF Value™ is CHF2.62, compared to a current price of CHF1.05 — trading 59.9% below its estimated fair value. The current Moat Score is 5. SHL Telemedicine's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For SHL Telemedicine (LTS:0QMX), the current Moat Score is 5 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SHL Telemedicine (LTS:0QMX) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of CHF1.05 is trading 59.9% below its estimated GF Value™ of CHF2.62. GuruFocus considers SHL Telemedicine to be Possible Value Trap.

Key valuation signals for LTS:0QMX:

  • Moat Score: 5
  • GF Value™: CHF2.62 vs. price of CHF1.05 (59.9% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the LTS:0QMX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SHL Telemedicine Business Description

Other Exchanges SHLTN:Switzerland
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
45GF Score

Get the complete analysis for LTS:0QMX

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF1.05
Price
CHF2.62
GF Value